• Tacalcitol Monohydrate: Bridging Dermatology and Oncology

  2026-06-30

  Tacalcitol monohydrate—a synthetic analog of vitamin D3—has redefined the landscape for translational researchers who seek both mechanistic depth and clinical relevance. This thought-leadership article explores its dual action as a vitamin D receptor agonist and a synergistic partner in cancer therapy, contextualizing rigorous evidence and experimental parameters while mapping a path from bench to bedside.

• Tacalcitol Monohydrate (SKU C8714): Precision in Cell Assays

  2026-06-30

  Tacalcitol monohydrate (SKU C8714) offers reproducible, data-backed performance for nerve growth factor induction, cancer cell sensitization, and dermatological research. This article provides scenario-driven guidance for biomedical researchers and lab technicians, emphasizing validated concentrations, protocol optimization, and selection criteria to enhance experimental reliability.

• Tirbanibulin Suppresses HPV Oncoproteins via Src-MEK Pathway

  2026-06-29

  This study demonstrates that tirbanibulin significantly inhibits cell proliferation and downregulates key oncogenic proteins, including HPV E6 and E7, in HPV-18-positive HeLa cells by targeting the Src-MEK signaling axis. These findings expand mechanistic understanding of tirbanibulin's action against HPV-associated cancer pathways and suggest broader therapeutic potential.

• Cathepsin B inhibitor CA-074: Protocols and Workflow Guidanc

  2026-06-29

  Cathepsin B inhibitor CA-074 (SKU A1926) addresses key needs in the selective inhibition of cathepsin B for research on cancer metastasis, neurotoxicity, and immune modulation. This article outlines actionable protocols, workflow checks, and boundaries to ensure reliable application of CA-074 in cell-based and biochemical assays, while clarifying where its use is most appropriate.

• DiscoveryProbe Bioactive Compound Library Plus: Applied Work

  2026-06-28

  The DiscoveryProbe™ Bioactive Compound Library Plus (SKU: L1022P) empowers modern biomedical researchers with a rigorously validated, diverse set of 5,072 bioactive molecules ready for high-throughput screening. This article translates the latest referenced advances in thermal shift assays and pathway interrogation into actionable, stepwise protocols and troubleshooting strategies, enabling confident target validation across apoptosis, cancer, and immunology research.

• Risedronate Sodium: FPPS Inhibitor Workflows for Bone and Lu

  2026-06-27

  Risedronate Sodium is a benchmark FPPS inhibitor, enabling targeted bone metabolism and alveolar macrophage research with advanced delivery options. Its versatility in osteoporosis and emphysema models, including high-efficiency inhaled microspheres, positions it as a gold-standard tool for translational studies.

• Calcitriol in Bone Homeostasis: New Insights from NFIA Signa

  2026-06-26

  Explore how Calcitriol, the active metabolite of vitamin D3, regulates bone homeostasis and immune modulation via NFIA and cytokine pathways. This article offers advanced mechanistic analysis and practical guidance, distinct from existing application-centric content.

• Risedronate Sodium: Applied Protocols for Bone and Tumor Res

  2026-06-26

  Risedronate Sodium is a potent FPP synthase inhibitor enabling precise, reproducible workflows across bone metabolism and cancer research. Explore stepwise protocols, advanced delivery formats, and data-driven troubleshooting tips to maximize your in vitro and in vivo studies.

• XPO1 Inhibition by Eltanexor Modulates Wnt/β-Catenin in CRC

  2026-06-25

  The referenced study demonstrates that Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, reduces colorectal cancer tumorigenesis by modulating the Wnt/β-catenin signaling pathway and decreasing COX-2 expression. These findings provide mechanistic insight and preclinical evidence for XPO1 inhibition as a targeted chemopreventive strategy in colorectal cancer models.

• Mitochondrial Calcium Signaling Suppresses Ferroptosis in Ca

  2026-06-25

  This study identifies mitochondrial calcium influx via the mitochondrial calcium uniporter (MCU) as a crucial suppressor of ferroptotic cell death in cancer. By linking mitochondrial metabolism to ferroptosis resistance through acetyl-CoA-mediated GPX4 regulation, the research opens new avenues for targeting tumor cell survival mechanisms.

• NFIA Coordinates Osteoclast and Osteoblast Differentiation i

  2026-06-24

  This study uncovers nuclear factor I/A (NFIA) as a pivotal regulator of bone homeostasis by orchestrating the differentiation balance between osteoclasts and osteoblasts in mesenchymal stem/progenitor cells. The findings reveal novel transcriptional mechanisms linking NFIA to age-related osteoporosis and highlight its potential as a research target in bone biology.

• Hypoxia and Immunometabolism: Mechanisms Shaping Tumor Micro

  2026-06-23

  This review elucidates how hypoxia-driven metabolic reprogramming in tumor cells and immune cells fosters an immunosuppressive tumor microenvironment (TME), advancing our understanding of cancer biology and potential therapeutic strategies. The work highlights the dynamic interplay between oxygen deprivation, altered glucose metabolism, and immune regulation as critical determinants of malignant progression.

• Tacalcitol Monohydrate: Precision Modulation in Cancer and S

  2026-06-23

  Explore Tacalcitol monohydrate, a synthetic analog of vitamin D3, through an advanced scientific lens. This article reveals new mechanistic insights and protocol guidance for maximizing its utility in cancer and dermatological research.

• Sex Differences in Cannabinoid Withdrawal: Insights from WIN

  2026-06-22

  Brewer et al. systematically characterize somatic and anxiety-like withdrawal behaviors in male and female rats exposed to the synthetic cannabinoid agonist WIN 55,212-2. Their findings reveal sex-specific patterns in withdrawal symptoms and locomotor activity, advancing preclinical understanding of cannabinoid dependence and informing future endocannabinoid system modulator research.

• Astrocyte Heterogeneity Mapped Across Mouse and Marmoset Bra

  2026-06-22

  Schroeder et al. deliver a comprehensive transcriptomic atlas charting astrocyte diversity across brain regions and developmental stages in mouse and marmoset. Their work reveals region- and species-specific gene expression and morphological distinctions, providing a critical framework for understanding astrocyte specialization in health and disease.

16369 records 1/1092 page Next 12345 下5页 Last page